Articles Posted in FTC

Close Coordination Between FTC and EC on Essilor and Luxottica Antitrust Reviews
Doyle, Barlow & Mazard PLLC

On March 1, 2018, Essilor International S.A. (“Essilor”) and Luxottica Group S.p.A. (“Luxottica”) announced that the proposed combination between the two companies has been cleared by both the FTC and the EC without conditions. Critics raised concerns about the merged company’s shutting out competitors, which would leave consumers with fewer options and less freedom of…

Continue reading ›
FTC Says No More Divestitures of Complex Pipeline Products to Resolve Future Competition Concerns in Pharmaceutical Mergers
Doyle, Barlow & Mazard PLLC

On February 2, 2018, Bruce Hoffman, the Federal Trade Commission’s (“FTC”) acting Director of the Bureau of Competition, announced at the Global Competition Review Seventh Annual Antitrust Law Leaders Forum that the FTC will no longer accept divestitures of inhalant and injectable pipeline drugs in pharmaceutical mergers.  Historically, the FTC had accepted divestiture of pipeline…

Continue reading ›
Business as Usual:  Trump Administration Targets Consummated Mergers
Doyle, Barlow & Mazard PLLC

Historically, the FTC and DOJ have sought to unwind consummated mergers that are deemed to be anticompetitive.  During Trump’s first year in office, the FTC and DOJ have demonstrated their willingness to unwind anticompetitive mergers that somehow sneaked by the regulators. FTC Seeks to Unwind Merger of Prosthetic Knee Manufacturers On December 20, 2017, the…

Continue reading ›
Power Buyer Defense Not Enough: FTC Wins PI Hearing Against Sanford Health
Doyle, Barlow & Mazard PLLC

On December 15, 2017, a federal district court granted the Federal Trade Commission’s (“FTC”) and North Dakota Attorney General’s request for a preliminary injunction against Sanford Health’s proposed acquisition of Mid Dakota Clinic, a large multispecialty group, pending the FTC’s administrative trial on the merits scheduled for January of 2018.  FTC v. Sanford Health, et…

Continue reading ›
FTC is the New Cop on the Broadband Beat
Doyle, Barlow & Mazard PLLC

On December 14, 2017, the Federal Communications Commission (FCC) voted 3-2 to adopt the Restoring Internet Freedom Order and in doing so, scrapped its net neutrality rules that were put in place in 2015. Net Neutrality is a principle that allows for an open and free internet.  The Internet Service Providers (ISPs”) are the gatekeepers…

Continue reading ›
Senator Warren Criticizes Current State of Antitrust Enforcement
Doyle, Barlow & Mazard PLLC

On December 6, 2017, Senator Elizabeth Warren sharply criticized the state of antitrust enforcement in a speech at the Open Markets Institute. She said that antitrust enforcers adopted the Chicago School principles, which narrowed the scope of the antitrust laws and allowed mega-mergers to proceed resulting in many concentrated industries.  She believes that antitrust enforcers…

Continue reading ›
Trump’s FTC Challenges Tronox’s Acquisition of Cristal
Doyle, Barlow & Mazard PLLC

On December 5, 2017, the Federal Trade Commission (“FTC”) issued an administrative complaint challenging Tronox Limited’s proposed acquisition of Cristal, a merger of two of the top three suppliers of chloride process titanium dioxide (“TiO2”) in the North American market. Background On February 21, 2017, Tronox inked a deal to buy Cristal for $1.67 billion…

Continue reading ›
FTC Clears ACT’s Acquisition of Jet-Pep
Doyle, Barlow & Mazard PLLC

On November 22, 2017, the FTC announced that retail fuel station and convenience store operator Alimentation Couche-Tard Inc. (“ACT”) agreed to divest three fuel stations in Alabama to settle FTC charges that ACT’s proposed acquisition of Jet-Pep, Inc. (“Jet-Pep”) would violate federal antitrust law. Under the terms of the deal, ACT will acquire ownership or…

Continue reading ›
FTC Remains Mindful of Minority Interests in Merger Review
Doyle, Barlow & Mazard PLLC

On November 3, 2017, the FTC announced that Red Ventures and Bankrate agreed to a divestiture of Bankrate’s Caring.com business unit to settle FTC charges that their $1.4 billion merger would likely harm competition in the market for third-party paid referral service for senior living facilities. According to the FTC’s complaint, Red Ventures was not…

Continue reading ›
FTC Settles With Integra on its Acquisition of J&J’s Codman Neuro Division
Doyle, Barlow & Mazard PLLC

On September 27, 2017, the FTC announced that Integra LifeSciences Holdings Corp. (“Integra”) and Johnson & Johnson (“J&J”) agreed to a divestiture of five neurosurgical medical device product lines to settle FTC allegations that Integra’s proposed $1 billion acquisition of J&J’s Codman Neuro division (“Codman”) would negatively impact competition in those markets. Competitive Issue Both…

Continue reading ›
Aerial view of Washington DC cityscape from Arlington Virginia USA.

Contact Us

Fill out the form or call us at (202) 589-1834 to schedule your consultation.